Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma
Identification of actionable alterations in colorectal cancer are leading to the development of novel treatment strategies - Mayo Clinic
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis - The Lancet Oncology
,0.jpg "Progress towards individualized treatment of colorectal cancer UAB Barcelona")
Progress towards individualized treatment of colorectal cancer UAB Barcelona
Prevalence of KRAS, NRAS and BRAF mutations in patients with colorectal... | Download Scientific Diagram
IJMS | Free Full-Text | Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer | PNAS
KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness | OTT
The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational Study - Chida - 2021 - The Oncologist - Wiley Online Library
The Trouble With KRAS - Cancer Commons
Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
Chemically modified MIR143-3p exhibited anti-cancer effects by impairing the KRAS network in colorectal cancer cells: Molecular Therapy - Nucleic Acids
APMG Colon Molecular Pathways
Les biomarqueurs prédictifs dans le cancer colorectal
Frontiers | Targeting KRAS: The Elephant in the Room of Epithelial Cancers
The current understanding on the impact of KRAS on colorectal cancer - ScienceDirect
Can KRAS Positive Colorectal and Lung Cancer Finally be Targeted? - CancerConnect
Colorectal Cancer
Frontiers | Prognostic and therapeutic impact of the KRAS G12C mutation in colorectal cancer
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
Kras in metastatic colorectal cancer
KRAS Mutation in Colon Cancer: A Marker of Resistance to EGFR-I Therapy | Annals of Surgical Oncology
IJMS | Free Full-Text | Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?
:max_bytes(150000):strip_icc()/kras-g12c-mutation-in-nsclc-4843957-v3-456bf340786c481b857d044b6a8cb307-b4828f2507074811b94472745e488299.png "KRAS Positive Lung Cancer: Testing and Management")
KRAS Positive Lung Cancer: Testing and Management
:quality(90)/ "Roche | Cancer du côlon : les principales mutations")
Roche | Cancer du côlon : les principales mutations
